Cargando…
STAT3 regulated miR-216a promotes ovarian cancer proliferation and cisplatin resistance
Cisplatin is the first-line treatment for ovarian cancer. However, the clinical outcome of cisplatin treatment in ovarian cancer is hindered by cancer resistance. Here we aim to explore the role and mechanism of miR-216a in the cisplatin resistance of ovarian cancer. The effects of miR-216a overexpr...
Autores principales: | Jin, Pengfei, Liu, Yanjun, Wang, Ruijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131203/ https://www.ncbi.nlm.nih.gov/pubmed/30061175 http://dx.doi.org/10.1042/BSR20180547 |
Ejemplares similares
-
miR-4461 Regulates the Proliferation and Metastasis of Ovarian Cancer Cells and Cisplatin Resistance
por: Dou, Lei, et al.
Publicado: (2021) -
LncRNA CTBP1-AS2 regulates miR-216a/ PTEN to suppress ovarian cancer cell proliferation
por: Cui, Kaiying, et al.
Publicado: (2020) -
Syntenin Regulated by miR-216b Promotes Cancer Progression in Pancreatic Cancer
por: Zu, Fuqiang, et al.
Publicado: (2022) -
Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun
por: Huang, Gang, et al.
Publicado: (2017) -
HOTTIP Predicts Poor Survival in Gastric Cancer Patients and Contributes to Cisplatin Resistance by Sponging miR-216a-5p
por: Zhao, Rui, et al.
Publicado: (2020)